Recent Product Launches VIVEX Biologics has launched innovative products like Cygnus Matrix Disks and CYGNUS Dual amniotic allograft, showcasing a commitment to cutting-edge solutions and opening avenues for sales expansion.
Strategic Partnerships The company has established partnerships with industry leaders like Onkos Surgical, Novastep Inc., and Xtant Medical for bone and tissue grafts, foot and ankle implants, and regenerative medicine products. Leveraging these networks can lead to collaborative sales ventures and market penetration opportunities.
Experienced Leadership With Lisa Colleran as CEO, a prominent figure in the regenerative medicine field, VIVEX Biologics possesses strong leadership that can drive sales growth through industry connections and expertise.
Regenerative Medicine Focus Specializing in regenerative medicine, particularly orthopaedic, spine, wound, and soft tissue indications, VIVEX Biologics is well-positioned to capitalize on the increasing demand for advanced biologics and therapeutic solutions.
Revenue & Comparable Companies With a revenue ranging from $50M to $100M, VIVEX Biologics competes with similar companies like Epic Pharma and Vertical Pharmaceuticals. Analyzing the sales strategies of these competitors can provide insights into capturing a larger market share.
1-888-653-2347 
support@leadiq.com 
